Preeclampsia: From Inflammation to Immunoregulation.

Area of Science:

• Reproductive immunology
• Maternal-fetal medicine
• Pathophysiology of preeclampsia

Background:

• Preeclampsia affects 5-7% of pregnancies globally, causing maternal mortality and premature births.
• Associated with hypertension, fetal growth restriction, endothelial dysfunction, and chronic immune activation.
• Pathogenesis involves placental ischemia due to shallow trophoblast invasion and inadequate uterine spiral artery remodeling.

Purpose of the Study:

• To review studies on immunoregulatory factors in the Reduced Uterine Perfusion Pressure (RUPP) rat model of preeclampsia.
• To highlight the role of immune imbalance in preeclampsia pathophysiology.
• To explore potential therapeutic strategies for preeclampsia.

Main Methods:

• Utilized the Reduced Uterine Perfusion Pressure (RUPP) rat model to simulate placental ischemia.
• Examined immune alterations, including changes in T cells and cytokines.
• Assessed the effects of immunoregulatory interventions.

Main Results:

• The RUPP rat model demonstrated that immune imbalance mediates preeclampsia pathophysiology.
• Identified specific mechanisms of immunoregulation with potential therapeutic benefits.
• Showcased positive effects of immunoregulatory factors in the RUPP model.

Conclusions:

• Immune imbalance, characterized by proinflammatory and regulatory T cell shifts, is central to preeclampsia.
• Immunoregulatory interventions show promise in the RUPP rat model.
• Restoring immune balance may offer a therapeutic strategy for improving maternal and fetal outcomes in preeclampsia.